Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review

JAMA

Volumn 283, Issue 9, 2000, Pages 1183-1188

  Pearson, Gail D ^a   Veille, Jean Claude ^b   Rahimtoola, Shahbudin ^c   Hsia, Judith ^d   Oakley, Celia M ^e   Hosenpud, Jeffrey D ^f   Ansari, Aftab ^g   Baughman, Kenneth L ^h  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CHILDBIRTH; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE ORGANIZATION; HEART LEFT VENTRICLE FAILURE; HUMAN; LETHALITY; MEDICAL INFORMATION; MEDICAL LITERATURE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0034161318     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.9.1183     Document Type: Article

References (43)

1. Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci. 1937;19: 185-199.
2. Veille JC. Peripartum cardiomyopathies: a review. Am J Obstet Gynecol. 1984;148:805-818.
3. Demakis JC, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44:1053-1061.
4. Witlin AG, Mable WC, Sibai BM. Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol. 1997;176:182-188.
5. Costanzo-Nordin MR, O'Connell JB. Peripartum cardiomyopathy in the 1980's: etiologic and prognostic consideration and review of the literature. Prog Cardiol. 1989;2:225-239.
6. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol. 1992;69:1458-1466.
7. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971;44:964-968.
8. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;180:860-870.
9. Cunningham FG, Pritchard JA, Hankins GD, Anderson PL, Lucas MJ, Armstrong KF. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events? Obstet Gynecol. 1986;67:157-168.
10. Ventura SJ, Peters KD, Martin JA, Maurer JD. Births and deaths: United States, 1996. Mon Vital Stat Rep. 1997;46(1 suppl 2):1-40.
11. Pierce JA. Familial occurrence of postpartal heart failure. Arch Intern Med. 1962;111:163-166.
12. Massad LS, Reiss CK, Mutch DG, Hasket EJ. Family peripartum cardiomyopathy after molar pregnancy. Obstet Gynecol. 1993;81:886-888.
13. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995;129:421-422.
14. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 1982;307:731-734.
15. Chow LH, Radio SH, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol. 1989;14:915-920.
16. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for the role of sampling error. Mayo Clinic Proc. 1989;64:1235-1245.
17. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990;81:922-928.
18. Farber PA, Glasgow LA. Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice. Am Heart J. 1970;80:96-102.
19. Lyden DC, Huber SA. Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone. Cell Immunol. 1984;87:462-472.
20. Artlett CM, Jimenez SA, Smith JB. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med. 1998;338:1186-1191.
21. Nelson JL, Bianchi DW, Ober C, et al. Microchimerism and HLA compatible relationships of pregnancy in scleroderma. Lancet. 1998;351:559-562.
22. Nelson JL. Pregnancy, persistent microchimerism and autoimmune disease. J Am Med Womens Assoc. 1998;53:31-32.
23. Bianchi BW, DeMaria MA, Sylvester S, Weil GJ. Male fetal progenitor cells persist in maternal blood for as long as 27 years post partum. Proc Natl Acad Sci U S A. 1996;93:705-708.
24. Ansari AA, Neckelmann N, Wang YC, Gravanis MB, Sell KW, Herskowitz A. Immunologic dialogue between cardiac myocytes, endothelial cells, and mononuclear cells. Clin Immunol Immunopathol. 1993;68: 208-214.
25. Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J. 1997;133:53-59.
26. Mone SM, Sanders SP, Colan SD. Control mechanisms for physiological hypertrophy of pregnancy. Circulation. 1996;94:667-672.
27. Julian DG, Szekeley P. Peripartum cardiomyopathy. Prog Cardiovasc Dis. 1985;27:223-246.
28. Ludwig P, Fischer E. Peripartum cardiomyopathy. Aust N Z J Obstet Gynaecol. 1997;37:156-160.
29. Mann DL. Stress activated cytokines and the heart. Cytokine Growth Factor Rev. 1996;7:341-354.
30. Coulson CC, Thorp JM Jr, Mayer DC, Cefalo RC. Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol. 1996;87:610-612.
31. Kothari SS. Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? Int J Cardiol. 1977;60:111-114.
32. Rahimtoola SH, Tak T. The use of digitalis in heart failure. Curr Probl Cardiol. 1996;21:781-853.
33. Packer M, O'Connor CM, Ghali JK, et al, for the PRAISE Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107-1114.
34. Mohler ER, Sorensen LC, Ghali JK, et al. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. J Am Coll Cardiol. 1997; 30:35-41.
35. Frishman WH. Carvedilol. N Engl J Med. 1998; 339:1759-1765.
36. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996; 334:1349-1355.
37. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:269-275.
38. Bozkurt B, Villaneuva FS, Holubkov R, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999;34: 177-180.
39. Keogh A, Macdonald P, Spratt P, Marshman D, Larbalestier R, Kaan A. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant. 1994;13:202-207.
40. O'Connell JB, Costanzo-Nordin MR, Subramanian R, et al. Peripartum cardiomyopathy: clinical hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol. 1986;8:52-56.
41. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J. 1991;121:1776-1778.
42. Lampert M, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol. 1997; 176(1 pt 1):189-195.
43. Ceci O, Berardesca C, Caradonna F, Corsano P, Guglielmi R, Nappi L. Recurrent peripartum cardiomyopathy. Eur J Obstet Gynecol Reprod Biol. 1998; 76:29-30.